Trials / Conditions / Anaplastic Oligoastrocytoma

Anaplastic Oligoastrocytoma

29 registered clinical trials studyying Anaplastic Oligoastrocytoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) G NCT04623931	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant NCT03180502	NRG Oncology	Phase 2
Completed	Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children NCT03043391	Istari Oncology, Inc.	Phase 1
Completed	Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma NCT03072134	Northwestern University	Phase 1
Unknown	Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas NCT02795364	Huashan Hospital	N/A
Recruiting	Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Re NCT02800486	Northwell Health	Phase 2
Unknown	A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Mul NCT05600491	Sun Yat-sen University	Phase 3
Completed	A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma NCT02026271	Alaunos Therapeutics	Phase 1
Unknown	A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas NCT02629757	Sun Yat-sen University	Phase 3
Completed	Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High- NCT02015819	City of Hope Medical Center	Phase 1
Terminated	Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma NCT02168270	University of Nebraska	Phase 1
Completed	Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brai NCT01985256	Tocagen Inc.	Phase 1
Terminated	Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas NCT01849952	Dartmouth-Hitchcock Medical Center	—
Completed	Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gl NCT01922076	National Cancer Institute (NCI)	Phase 1
Completed	Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II T NCT01847235	Seoul National University Hospital	Phase 2
Withdrawn	Re-irradiation of High Grade Gliomas: a Quality of Life Study NCT01711580	Maastricht Radiation Oncology	—
Terminated	Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas NCT01721577	Rush University Medical Center	Phase 1 / Phase 2
Completed	Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma NCT01250470	Roswell Park Cancer Institute	Phase 1
Unknown	A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Glio NCT01765088	Sun Yat-sen University	Phase 3
Unknown	Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma NCT01656980	Shandong Lanjin Pharmaceuticals Co.,Ltd	Phase 3
Unknown	Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma NCT01637753	Shandong Lanjin Pharmaceuticals Co.,Ltd	N/A
Completed	BIBF 1120 for Recurrent High-Grade Gliomas NCT01380782	Patrick Y. Wen, MD	Phase 2
Completed	Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820	Roswell Park Cancer Institute	Phase 1
Completed	Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Re NCT01470794	Tocagen Inc.	Phase 1
Completed	Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients NCT01189266	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Mal NCT01156584	Tocagen Inc.	Phase 1
Completed	Sorafenib in Newly Diagnosed High Grade Glioma NCT00884416	University Hospital, Geneva	Phase 1
Completed	Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previo NCT00303849	OHSU Knight Cancer Institute	Phase 1 / Phase 2
Terminated	Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) NCT00035373	National Cancer Institute (NCI)	—